Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.

Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Abstract Text:

    sarah bremSarah Brem,betty tylerBetty Tyler,khan liKhan Li,gustavo pradillaGustavo Pradilla,federico legnaniFederico Legnani,justin caplanJustin Caplan,henry bremHenry Brem,

    PURPOSE: Dose-limiting adverse effects of thrombocytopenia and leukopenia prevent augmentation of current temozolomide (TMZ) dosing protocols; therefore, we hypothesized that the direct intracranial delivery of TMZ would lead to improved efficacy in an animal model of malignant glioma in an animal model. METHODS: Temozolomide was incorporated into biodegradable polymers and the active drug was released over 80 h. Intracranial toxicity was assessed in F344 rats and a maximally tolerated dose was not achieved. RESULTS: In vivo drug biodistribution demonstrated that intracranial concentrations of TMZ increased threefold compared with orally delivered TMZ. In a rodent glioma model, animals treated with a single TMZ polymer (50% w/w) had a median survival of 28 days (P < 0.001 vs. controls, P < 0.001 vs. oral treatment), whereas animals treated with oral TMZ had a median survival of 22 days compared to control animals (median survival of 13 days). Animals treated with two TMZ polymers (50% w/w) had a median survival of 92 days (P < 0.001 vs. controls, P < 0.001 vs. oral treatment). The percentage of long-term survivors (LTS) for groups receiving intracranial TMZ ranged from 25 to 37.5%; there were no LTS with oral TMZ treatment. Animals treated with radiation therapy (XRT) and intracranial TMZ (median survival not reached, LTS = 87.5%) demonstrated improved survival compared to those with intracranial TMZ alone (median survival, 41 days; LTS = 37.5%), or oral TMZ and XRT (median survival, 43 days, LTS = 38.9%). CONCLUSIONS: The survival of tumor-bearing animals was improved with local delivery of TMZ compared with systemic administration. XRT in combination with intracranial TMZ did not cause additional toxicity and prolonged the survival even further.

    Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Publishing Authors By Initials

    s bremS Brem,b tylerB Tyler,k liK Li,g pradillaG Pradilla,f legnaniF Legnani,j caplanJ Caplan,h bremH Brem,

    For similar animals: animal population groups: animals, inbred strains: rats, inbred strains: rats, inbred f344 research abstracts see: animals: animal population groups: animals, inbred strains: rats, inbred strains: rats, inbred f344 research

    PUBMED ID PMID:

    MEDLINE DATE:

    Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Cancer chemotherapy and pharmacology

    VOLUME: 60

    Page Numbers: 643-50

    Journal Abbreviation: Cancer Chemother. Pharmacol.

    ISSN: 0344-5704

    DAY: 26

    MONTH: 01

    YEAR: 2007

    Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7806519

    Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Keywords Mesh Terms:

    KEYWORDS: Rats, Inbred F344

    MESH TERMS: radiotherapy

    Chemical & Substance for Abstract: Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Information

    Substance Name: temozolomide

    Registry Number: 85622-93-1

    Grant and Affiliation Information for Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.

    AFFILIATION: Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA. hbrem@jhmi.edu

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY: United States NCI

    GRANT: UO1-CA52857

    ACRONYM: CA

    MEDLINETA: Cancer Chemother Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News